RecruitingNot applicableNCT05360914

Hospital at Home for Elderly Acute Ill Patients

Studying Oculocerebral hypopigmentation syndrome, Cross type

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Defactum, Central Denmark Region
Principal Investigator
Camilla Palmhøj Nielsen, Ph.D
Defactum, Central Denmark Region
Intervention
Hospital at Home (HaH) treatment(other)
Enrollment
849 target
Eligibility
65 years · All sexes
Timeline
20222027

Study locations (3)

Collaborators

Interdisciplinary Centre for Organizational Architecture (ICOA), Aarhus University, Denmark · Research Center for Emergency Medicine, Aarhus University, Denmark · Viborg Regional Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05360914 on ClinicalTrials.gov

Other trials for Oculocerebral hypopigmentation syndrome, Cross type

Additional recruiting or active studies for the same condition.

See all trials for Oculocerebral hypopigmentation syndrome, Cross type

← Back to all trials